申请类型 NDA 申请号 212888 药品名称 CABENUVA KIT 活性成分 CABOTEGRAVIR; RILPIVIRINE 活性成分中文 暂无权限 执行时间 2024-09-26 持有公司 VIIV HLTHCARE 说明书 下载 VIP试用医疗器械查询APP下载客服中心常见问题数据可视化数据分析挖掘系统网站地图业务介绍友情链接 400-678-0778 投诉热线: (...
CABENUVA™, a co-packaged kit with two separate injectable medicines – Janssen’s rilpivirine and ViiV Healthcare’s cabotegravir – offers people living with HIV a new approach for maintaining viral suppression.1This novel regimen was co-developed as ...
Continuation Injections (CABENUVA 600-mg/900-mg Kit) After the 2 initiation doses given consecutively 1 month apart (Months 1 and 2), the recommended continuation injection doses (Month 4 onwards) of CABENUVA are a single 600-mg (3-mL) intramuscular injection of cabotegravir and a single...
The Cabenuva injection kit contains cabotegravir and rilpivirine as separate single-dose vials. There are two different kit strengths. Each dosing kit also contains 2 syringes, 2 syringe labels, 2 vial adapters, and 2 needles for intramuscular injection (23-gauge, 1½ inch). The vial stopper...
CABENUVA allows virologically suppressed adults living with HIV to maintain viral suppression while reducing their dosing schedule from 365 days to 12 days per year. VOCABRIA and CABENUVA should not be used in patients with known or suspected resistance to cabotegravir or rilpivirine. A kit with ...
申请类型 NDA 申请号 212888 药品名称 CABENUVA KIT 活性成分 CABOTEGRAVIR; RILPIVIRINE 活性成分中文 暂无权限 执行时间 2022-02-03 持有公司 VIIV HLTHCARE 说明书 下载 VIP试用医疗器械查询APP下载客服中心常见问题数据可视化数据分析挖掘系统网站地图业务介绍友情链接 400-678-0778 投诉热线: (...
申请类型 NDA 申请号 212888 药品名称 CABENUVA KIT 活性成分 CABOTEGRAVIR; RILPIVIRINE 活性成分中文 暂无权限 执行时间 2022-03-30 持有公司 VIIV HLTHCARE 说明书 下载 VIP试用医疗器械查询APP下载客服中心常见问题数据可视化数据分析挖掘系统网站地图业务介绍友情链接 400-678-0778 投诉热线: (...
VIP 数据库导航